P. Karayiannis

发表

Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease

M. Brunetto, F. Oliveri, F. Bonino, 1996 .

Fulminant hepatitis associated with hepatitis B virus e antigen–negative infection: Importance of host factors

H. Thomas, M. Thursz, S. Hadziyannis, 1995, Hepatology.

Whole genome analysis of hepatitis B virus from four cases of fulminant hepatitis: genetic variability and its potential role in disease pathogenicity

S. Hadziyannis, P. Karayiannis, H. Thomas, 1996, Journal of viral hepatitis.

Comparison of Hepatitis C Viral Loads in Patients with or without Coinfection with Different Genotypes

O. Kalinina, A. Schijman, L. García, 2004, Clinical Diagnostic Laboratory Immunology.

Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon‐α preparations

D. Forton, P. Karayiannis, E. D. Mangoni, 2003 .

Dental treatment as a risk factor for hepatitis B and C viral infection. A review of the recent literature.

S. Alavian, S. Porter, P. Karayiannis, 2013, Journal of gastrointestinal and liver diseases : JGLD.

Oral fluid and hepatitis A, B and C: a literature review.

S. Alavian, S. Porter, P. Karayiannis, 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Changes in immune cell populations in the periphery and liver of GBV-B-infected and convalescent tamarins (Saguinus labiatus)☆

N. Rose, S. Hood, N. Berry, 2014, Virus research.

The GB Viruses: An Update of Their Biology, Molecular Virology and Significance

P. Karayiannis, 2013 .

Which patients with chronic hepatitis B virus infection will respond to α‐interferon therapy? A statistical analysis of predictive factors

H. Thomas, M. Brook, P. Karayiannis, 1989, Hepatology.

Subclasses of antibodies to hepatitis B core antigen in chronic HBV infection: changes during treatment with alpha interferons and predictors of response.

H. Thomas, P. Karayiannis, M. McGarvey, 1989, Gut.

Persistence of chlamydial infection after treatment for neonatal conjunctivitis.

P. Karayiannis, D. Hobson, E. Rees, 1981, Archives of disease in childhood.

Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.

H. Thomas, M. Brook, J. Main, 1989, BMJ.

Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.

J. Harris, M. Brook, P. Karayiannis, 1989, Gut.

Effect of cyclosporin‐A in woodchucks with chronic hepatitis delta virus infection

R. Goldin, W. Carman, P. Karayiannis, 1992, Journal of medical virology.

Chronic hepatitis B virus infection: Viral replication and patterns of inflammatory activity: Serological, clinical and histological correlations

H. Thomas, P. Scheuer, F. Brenes, 1986 .

Oral Conditions Associated with Hepatitis C Virus Infection

S. Alavian, N. Mahboobi, P. Karayiannis, 2013, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis.

E. Holmes, H. Whittle, A. Hall, 2001, Journal of hepatology.

Prevalence of HBV core promoter/precore/core mutations in Gambian chronic carriers

H. Whittle, A. Hall, Maimuna Mendy, 2001, Journal of medical virology.

Diagnosing acute hepatitis C in HIV-infected patients: nucleic acid testing compared with antibody and antigen-antibody detecting methods.

E. Thomson, M. Mcclure, E. Nastouli, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.

S. Sherlock, A. Lok, H. Thomas, 1985, Gut.

Prevalence of a non‐A, non‐B‐associated antigen/antibody system detected by radioimmunoassay in acute and chronic liver disease

P. Karayiannis, K. Luo, D. M. Burns, 1983, Journal of medical virology.

Purification of woodchuck hepatitis surface antigen using a monoclonal antibody raised against the antigen.

R. Goldin, P. Karayiannis, J. Waters, 2001, Journal of virological methods.

Use of biotinylated probes in serum hepatitis B virus DNA detection.

H. Thomas, J. Saldanha, P. Karayiannis, 1987, Journal of virological methods.

The GB hepatitis viruses

P. Karayiannis, M. McGarvey, 1995, Journal of viral hepatitis.

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication.

S. Sherlock, A. Lok, H. Thomas, 2008, Liver.

Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.

S. Sherlock, A. Lok, P. Karayiannis, 1983, Gut.

The hepatitis C virus NS3/4A protease complex interferes with pathways of the innate immune response.

P. Karayiannis, 2005, Journal of hepatology.

The expression of hepatitis B virus polymerase in hepatocytes during chronic HBV infection

H. Thomas, R. Goldin, P. Karayiannis, 1996, Journal of viral hepatitis.

Recombinant vaccinia viruses expressing hepatitis A virus structural polypeptides: detection of an anti-VP0 response in convalescent-phase sera

W. Carman, V. Hill, P. Karayiannis, 1995, Clinical and diagnostic laboratory immunology.

New Approaches to the Treatment of Chronic Hepatitis B

P. Karayiannis, A. Alexopoulou, L. Vasilieva, 2020, Journal of clinical medicine.

Failure to detect nucleic acid homology between some non‐A, Non‐B viruses and hepatitis B virus DNA

A. Zuckerman, H. Thomas, P. Karayiannis, 1983, Journal of medical virology.

Experimental infection of tamarins with human non‐a, non‐b hepatitis virus

P. Karayiannis, H. Thomas, B. Hurn, 1983, Journal of medical virology.

Hepatitis D virus

P. Karayiannis, 1998, Reviews in medical virology.

Partial control of hepatitis delta virus superinfection by immunisation of woodchucks (Marmota monax) with hepatitis delta antigen expressed by a recombinant vaccinia or baculovirus

J. Saldanha, R. Goldin, P. Karayiannis, 1993, Journal of medical virology.

Hepatitis B viral replication influences the expression of natural killer cell ligands

S. Khakoo, G. Raimondo, T. Pollicino, 2016, Annals of gastroenterology.

Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen.

A. Lok, P. Karayiannis, H. Thomas, 1985, British medical journal.

Integration of HBV-DNA may not be a prerequisite for the maintenance of the state of malignant transformation. An analysis of 110 liver biopsies.

A. Lok, E. Yeoh, C. Lai, 1986, Journal of hepatology.

Serological response and detection of viraemia in acute hepatitis C virus infection.

J. Chiba, T. Miyamura, I. Saito, 1992, Journal of hepatology.

Serological respo etedion of virae acute hepatitis C virus infection

H. Thomas, J. Chiba, T. Miyamura, 1992 .

High risk of non‐A non‐B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin

P. Karayiannis, H. Thomas, C. Lee, 1985, British journal of haematology.

ALEXANDER S NICHOLAS ROBERT ENGLAND DOMENIC A DEBIAS CHARLOTTE GREENE WALTER EHRENFEUCHTER DAVID HEILIG

A. Lok, P. Karayiannis, H. Thomas, 2006 .

Acute and chronic hepatitis delta virus infection: Direct or indirect effect on hepatitis B virus replication?

H. Thomas, F. Marongiu, P. Farci, 1988, Journal of medical virology.

Treatment options beyond IFNα and NUCs for chronic HBV infection: expectations for tomorrow

P. Karayiannis, G. Baltayiannis, 2014, Journal of viral hepatitis.

Interferon therapy is effective in treatment of hepatitis B-induced polyarthritis

H. Thomas, P. Karayiannis, L. Scully, 1992, Digestive Diseases and Sciences.

Natural history and molecular biology of hepatitis G virus/GB virus C.

R. Zampino, P. Karayiannis, H. Thomas, 1998, Clinical and diagnostic virology.

Current Status of Hepatitis G Virus (GBV‐C) in Transfusion: Is It Relevant?

H. Thomas, P. Karayiannis, H. Thomas, 1997, Vox sanguinis.

Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease

H. Thomas, J. Chiba, T. Miyamura, 1992, Hepatology.

Improved serologic detection of hepatitis C virus with a paramagnetic microparticle assay using multiple antigenic sequences

T. Arima, J. Dienstag, D. Leahy, 1992, Transfusion.

Editing efficiency of hepatitis delta virus RNA is related to the course of infection in woodchucks.

H. Thomas, P. Karayiannis, J. Monjardino, 1995, The Journal of general virology.

Liver and biliary Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection

S. Hadziyannis, P. Karayiannis, L. Montano, 2006 .

A randomized study of the effects of adenine arabinoside 5′‐monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication

H. Thomas, P. Karayiannis, A. Dunk, 1985, Hepatology.

Studies of HBV replication during acute hepatitis followed by recovery and acute hepatitis progressing to chronic disease.

A. Lok, P. Farci, P. Karayiannis, 1985, Journal of hepatology.

Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection.

A. Lok, H. Thomas, S. Hadziyannis, 1984, Gut.

Quantitative aspects of chlamydial infection of the cervix.

P. Karayiannis, D. Hobson, J. Davies, 1980, The British journal of venereal diseases.

Inhibition of hepatitis delta virus (HDV) replication by lymphoblastoid human alpha interferon.

P. Farci, P. Karayiannis, H. Thomas, 1987, Progress in clinical and biological research.

Molecular Variants of Hepatitis B Surface Antigen (HBsAg)

S. Alavian, H. Thomas, S. Jazayeri, 2013 .

NICE Guidelines and a Treatment Algorithm for the Management of Chronic Hepatitis B: A Review of 12 Years Experience in West London

H. Thomas, M. Thursz, Ashley S. Brown, 2008, Antiviral therapy.

Is lamivudine a safe and effective therapy for patients with chronic hepatitis B and advanced liver disease?

H. Thomas, P. Karayiannis, 2005, Nature Clinical Practice Gastroenterology &Hepatology.

Heart transplantation in patients with chronic hepatitis B: clinical evolution, molecular analysis, and effect of treatment.

G. Cirillo, A. Marrone, R. Zampino, 2005, Transplantation.

Immunologic mechanisms of cell lysis in Hepatitis B virus infection.

H. Thomas, A. Goodall, M. Pignatelli, 1984 .

Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV

E. Thomson, J. Eliahoo, M. Mcclure, 2009, AIDS.

Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.

A. Lok, H. Thomas, P. Karayiannis, 1985, Journal of hepatology.

Acute fulminant non-A, non-B hepatitis leading to chronic active hepatitis after treatment with cryoprecipitate.

P. Karayiannis, H. Thomas, C. Lee, 1985, Gut.

Immune response of patients with congenital coagulation disorders to hepatitis b vaccine: Suboptimal response and human immunodeficiency virus infection

Christine A. Lee, P. Karayiannis, H. Thomas, 1989, Journal of medical virology.

Interferon therapy for chronic non‐A non‐B and chronic delta liver disease in haemophilia

Christine A. Lee, P. Karayiannis, H. Thomas, 1989, British journal of haematology.

Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals

P. Karayiannis, A. Alexopoulou, 2015, Annals of gastroenterology.

Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men

Joseph Eliahoo, Emma C Thomson, P. Klenerman, 2010, Gut.

Developing a holistic contingency plan: Challenges and dilemmas for cancer patients during the COVID‐19

C. Demetriou, A. Charalambous, A. Quattrocchi, 2020, Cancer medicine.

In-vitro activity of monobactam, SQ 26,776, against Gram-negative bacteria.

C. Hart, P. Karayiannis, A. Percival, 1981, The Journal of antimicrobial chemotherapy.

Mapping of the cellular immune responses to woodchuck hepatitis core antigen epitopes in chronically infected woodchucks

M. Thursz, P. Karayiannis, H. Thomas, 1997, Journal of medical virology.

Restricted quasispecies variation following infection with the GB virus B.

T. Nastos, P. Karayiannis, M. McGarvey, 2008, Virus research.

The 5' untranslated region of GB virus B shows functional similarity to the internal ribosome entry site of hepatitis C virus.

B. Clarke, K. Grace, P. Karayiannis, 1999, The Journal of general virology.

Identification, prevalence and aspects of molecular biology of hepatitis G virus

P. Karayiannis, J. Pickering, H. Thomas, 1997, Journal of viral hepatitis.

Predicted secondary structure of the hepatitis G virus and GB virus‐A 5‘ untranslated regions consistent with an internal ribosome entry site

P. Karayiannis, J. Pickering, H. Thomas, 1997, Journal of viral hepatitis.

Hepatitis G virus: identification, prevalence and unanswered questions.

H. Thomas, P. Karayiannis, 1997, Gut.

Protracted alanine aminotransferase levels in tamarins infected with hepatitis A virus

P. Karayiannis, H. Thomas, P. Scheuer, 1990, Journal of medical virology.

Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread

P. Karayiannis, Peter Karayiannis, 2017, Hepatology International.

Clinical evaluation of a monoclonal assay for hepatitis B surface antigen:Identification of “HBsAg‐like” polypeptides non‐reactive in conventional radioimmunoassays

A. Lok, P. Karayiannis, H. Thomas, 1985, Journal of medical virology.

Enterically Transmitted Viral Hepatitis: Hepatitis A and Hepatitis E

H. Thomas, P. Karayiannis, 2011 .

The precore sequence of hepatitis B virus is required for nuclear localization of the core protein

S. Hadziyannis, P. Karayiannis, M. McGarvey, 1997, Hepatology.

Amino acid requirements of a Chlamydia trachomatis genital strain in McCoy cell cultures

P. Karayiannis, D. Hobson, 1981, Journal of clinical microbiology.

Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant.

H. Thomas, R. Goldin, P. Karayiannis, 1995, Journal of hepatology.

MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION

H. Thomas, W. Carman, S. Hadziyannis, 1989, The Lancet.

HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.

P. Karayiannis, A. Alexopoulou, 2014, World journal of gastroenterology.

Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.

D. Tiniakos, E. Hadziyannis, G. Papatheodoridis, 2011, Journal of hepatology.

Reactivation of precore variant hepatitis B virus in a child with severe aplastic anaemia

C. Aitken, R. Zampino, P. Karayiannis, 2001, Journal of medical virology.

Molecular Variants of the Precore, Core, and Core Promoter Regions of Hepatitis B Virus, and Their Clinical Significance

H. Thomas, W. Carman, P. Karayiannis, 2013 .

Detection and significance of a G1862T variant of hepatitis B virus in Chinese patients with fulminant hepatitis.

P. Karayiannis, Zhanhui Wang, H. Liao, 2002, The Journal of general virology.

Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission

G. Cirillo, A. Marrone, R. Zampino, 2002, American Journal of Gastroenterology.

Effect of antiviral treatment on alfa‐fetoprotein levels in HBV‐related cirrhotic patients: early detection of hepatocellular carcinoma

P. Karayiannis, K. Luo, Z. Liu, 2009, Journal of viral hepatitis.

Hepatitis B virus: old, new and future approaches to antiviral treatment.

P. Karayiannis, 2003, The Journal of antimicrobial chemotherapy.

A double blind, placebo‐controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

H. Thomas, J. Main, P. Karayiannis, 1996, Journal of viral hepatitis.

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV‐III antibodies to recombinant α‐interferon

J. Harris, P. Karayiannis, H. Thomas, 1987, Hepatology.

Vaccine-induced escape mutant of hepatitis B virus

A. Zuckerman, E. Tanzi, W. Carman, 1990, The Lancet.

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis

P. Karayiannis, 2012, Scientifica.

Established and Emerging Therapies for the Treatment of Viral Hepatitis

D. Forton, P. Karayiannis, 2006, Digestive Diseases.

Current therapies for chronic hepatitis B virus infection

P. Karayiannis, 2004, Expert review of anti-infective therapy.

Incidence of hepatitis B viraemia, detected using the polymerase chain reaction, after successful therapy of hepatitis B virus carriers with interferon–α

H. Thomas, W. Carman, P. Karayiannis, 1991, Journal of medical virology.

Treatment of hepatitis B virus infection with interferon. Factors predicting response to interferon.

H. Thomas, G. Brook, P. Karayiannis, 1991, Journal of hepatology.

Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatment.

P. Karayiannis, H. Thomas, J. Mcdonald, 1987, Journal of hepatology.

Natural history of chronic hepatitis B virus infection in taiwan: Studies of hepatitis B virus DNA in serum

H. Thomas, C. Chu, Y. Liaw, 1985, Hepatology.

Hepatitis B Virus (Hepadnaviridae)

P. Karayiannis, 2021, Encyclopedia of Virology.

Core mutations in patients with acute episodes of chronic HBV infection are associated with the emergence of new immune recognition sites and the development of high IgM anti‐HBc index values

T. Nastos, A. Archimandritis, P. Karayiannis, 2009, Journal of medical virology.

Hepatitis B Virus: General Features

H. Thomas, P. Karayiannis, H. Thomas, 2008 .

Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen–negative Chinese carriers

G. Lau, Jinjun Cheng, Jian Sun, 2001, Hepatology.

Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop‐codon and basic core promoter mutations

M. Theodorou, P. Karayiannis, A. Alexopoulou, 2006, Journal of viral hepatitis.

Hepatitis B virus basal core promoter mutations show lower replication fitness associated with cccDNA acetylation status.

S. Khakoo, G. Raimondo, D. Stampoulis, 2016, Virus research.

Effect of basal core promoter and pre-core mutations on hepatitis B virus replication.

H. Thomas, R. Watson, P. Karayiannis, 2008, The Journal of general virology.

An outbreak of HBV and HCV infection in a paediatric oncology ward: Epidemiological investigations and prevention of further spread

P. Pumpens, Stefan Ross, M. Roggendorf, 2003, Journal of medical virology.

Low HBeAg Serum Levels Correlate with the Presence of the Double A1762T/G1764A Core Promoter Mutation and a Positive Response to Interferon in Patients with Chronic Hepatitis B Virus Infection

A. Marrone, R. Zampino, P. Karayiannis, 2003, Intervirology.

Sequential analysis of hepatitis B virus core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment

E. D. del Giudice, G. Cirillo, A. Marrone, 2002, Journal of viral hepatitis.

A randomised controlled trial of interferon alfa 2A for the treatment of chronic hepatitis B virus infection: Factor, that influence response

M. Brook, P. Karayiannis, H. Thomas, 1989 .

Treatment of chronic hepatitis delta virus (HDV) infection with human lymphoblastoid alpha interferon.

J. Saldanha, J. Gerin, P. Farci, 1989, The Quarterly journal of medicine.

Clinical trial Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

P. Karayiannis, I. Weller, S. Galpin, 2006 .

Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood‐acquired chronic hepatitis B virus infection

M. Brook, J. Main, P. Karayiannis, 1993, Alimentary pharmacology & therapeutics.

Predictive model of response to therapy with interferon in patients with chronic hepatitis B virus infection: A methodological note

G. Leandro, M. Brook, P. Karayiannis, 1990, Hepatology.

Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment.

H. Thomas, P. Karayiannis, S. Kanatakis, 1990, Journal of hepatology.

A preliminary study of hepatitis B virus replication during short-term (7-day) social drinking.

W. J. Jenkins, P. Karayiannis, H. Thomas, 1987, Alcoholism, clinical and experimental research.

Perinatal transmission of hepatitis B virus in Kenya: Its relation to the presence of serum HBV‐DNA and Anti‐HBe in the mother

P. Tukei, P. Karayiannis, H. Thomas, 1986, Journal of medical virology.

The removal of hepatitis B virus from factor VIII concentrates by fractionation on ethylene maleic anhydride polyelectrolyte

P. Karayiannis, H. Thomas, S. Galpin, 1984, Journal of medical virology.

Aetiology of acute sporadic hepatitis in adults in kenya

P. Tukei, M. V. Shah, P. Karayiannis, 1984, Journal of medical virology.

Thomas Methods PATIENTS Between August 1980 and November 1981 , all patients who had been HBsAg and HBeAg positive for more than six months attending the Department of Medicine at the Royal Free

S. Sherlock, H. Thomas, A. Mindel, 2022 .

Hepatitis B Surface Antigen (HBsAg) Variants

H. Thomas, A. Basuni, W. Carman, 2007 .

Molecular Variations in the Core Promoter, Precore and Core Regions of Hepatitis B Virus, and their Clinical Significance

H. Thomas, W. Carman, P. Karayiannis, 2007 .

Serum Hepatitis B Surface Antigen Levels and Their Utility as a Predictor of Sustained Virological Response After Antiviral Treatment

P. Karayiannis, 2012, Hepatitis monthly.

Interferon‐α therapy in HBeAg‐negative chronic hepatitis B: a long‐term prospective study from north‐western Greece

K. Katsanos, E. Tsianos, P. Karayiannis, 2006, Alimentary pharmacology & therapeutics.

A pilot study of BW A515U (6-deoxyacyclovir) in chronic hepatitis B virus infection.

H. Thomas, R. Tedder, P. Karayiannis, 1986, Journal of Hepatology.

Interactions between hepatotropic viruses in patients with haemophilia.

P. Farci, P. Karayiannis, H. Thomas, 1985, Journal of Hepatology.

Hepatitis B Surface Antigen Variant with Multiple Mutations in the a Determinant in an Agammaglobulinemic Patient

P. Karayiannis, S. Jammeh, A. Alexopoulou, 2004, Journal of Clinical Microbiology.

Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon‐treated patient

H. Thomas, W. Lim, J. Hou, 2001, Journal of viral hepatitis.

A unique insertion in the S gene of surface antigen–negative hepatitis B virus Chinese carriers

H. Thomas, P. Karayiannis, J. Hou, 1995, Hepatology.

Intra-familial transmission of hepatitis B virus in Italy: phylogenetic sequence analysis and amino-acid variation of the core gene.

M. Thursz, R. Zampino, M. Chiaramonte, 2002, Journal of hepatology.

Replicative competence of the T131I, K141E, and G145R surface variants of hepatitis B Virus.

H. Thomas, P. Karayiannis, S. Jammeh, 2007, The Journal of infectious diseases.

Emergence of the long form of hepatitis delta virus antigen in transfected cells after intrahepatic transfection and during natural infection.

H. Thomas, S. Hadziyannis, P. Karayiannis, 1993, Progress in clinical and biological research.

Emergence and selection of HBV variants in an anti-HBe positive patient persistently infected with quasi-species.

S. Hadziyannis, P. Karayiannis, H. Thomas, 1997, Journal of hepatology.

The Epigenetic Control of Hepatitis B Virus Modulates the Outcome of Infection

P. Karayiannis, Lemonica Koumbi, 2016, Front. Microbiol..

Long‐term outcome of hepatitis B and hepatitis C virus co‐infection and single HBV infection acquired in youth

L. Adinolfi, G. Cirillo, A. Marrone, 2009, Journal of medical virology.

Which patients with chronic hepatitis B will respond to alpha interferon therapy? A statistical analysis of predictive factors

M. Brook, P. Karayiannis, H. Thomas, 1989 .

Tailored regimen of interferon alpha for HBeAg‐positive chronic hepatitis B: a prospective controlled study

P. Karayiannis, Q. Mao, J. Hou, 2008, Journal of viral hepatitis.

Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent

H. Margolis, M. Alter, J. Lifson, 1996, Science.

Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study.

M. Zali, P. Azimzadeh, S. Mohebbi, 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Editorial: HBsAg serum levels in HBeAg‐negative chronic HBV infection—is it a matter of genotype?

P. Karayiannis, A. Alexopoulou, 2018, Alimentary pharmacology & therapeutics.

Demographic changes of hepatitis B virus infection in Iran for the last two decades

M. Zali, P. Karayiannis, S. Ashtari, 2017, Gastroenterology and hepatology from bed to bench.

The detection of hepatitis viruses.

P. Karayiannis, 2011, Methods in molecular biology.

In situ hybridization studies in hepatitis A infection

H. Thomas, R. Goldin, P. Karayiannis, 1992, Hepatology.

Non-invasive investigation of liver isease in haemophilic patients

S. Hamilton-Dutoit, P. Karayiannis, H. Thomas, 2005 .

Non-invasive investigation of liver disease in haemophilic patients.

S. Hamilton-Dutoit, P. Karayiannis, H. Thomas, 1988, Journal of clinical pathology.

Hepatitis G virus/GBV‐C persistence: absence of hypervariable E2 region and genetic analysis of viral quasispecies in serum and lymphocytes

R. Zampino, P. Karayiannis, H. Thomas, 1999, Journal of viral hepatitis.

Pre‐S proteins in hepatitis b

A. Zuckerman, H. Thomas, A. Zanetti, 1989, Journal of medical virology.

Hepatitis A virus replication in tamarins and host immune response in relation to pathogenesis of liver cell damage

P. Scheuer, F. Brenes, M. Pignatelli, 1986, Journal of medical virology.

Severe exacerbation of liver disease during pregnancy in a thalassemic GBV‐C/HGV–positive patient and neonatal hepatitis in offspring

Y. Horsmans, A. Geubel, P. Karayiannis, 1999, Journal of medical virology.

Hepatitis G virus does not cause significant liver disease after liver transplantation

M. Bassendine, P. Karayiannis, G. Hess, 1998, Journal of viral hepatitis.

Different Genotypes Patients with or without Coinfection with Comparison of Hepatitis C Viral Loads in

O. Kalinina, A. Schijman, P. Karayiannis, 2004 .

Leucocyte glucose-6-phosphate dehydrogenase (G-6-PD) activity in G-6-PD deficient subjects

F. Tzortzatou-Stathopoulou, P. Karayiannis, N. Matsaniotis, 1980, European Journal of Pediatrics.

Genetic diversity between hepatitis G virus isolates: analysis of nucleotide variation in the NS-3 and putative 'core' peptide genes.

H. Thomas, P. Karayiannis, J. Pickering, 1997, The Journal of general virology.

TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROW

H. Prentice, A. Hoffbrand, M. Brenner, 1986, The Lancet.

Dynamic coinfection with multiple viral subtypes in acute hepatitis C.

P. Klenerman, Jennifer A. Smith, A. McLean, 2010, The Journal of infectious diseases.

Hepatitis G virus infection: clinical characteristics and response to interferon

M. Piatak, J. Kim, S. Hadziyannis, 1997, Journal of viral hepatitis.

HCV NS5A co-operates with PKR in modulating HCV IRES-dependent translation.

U. Georgopoulou, P. Karayiannis, K. Kalliampakou, 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Identification of Unique Hepatitis C Virus Quasispecies in the Central Nervous System and Comparative Analysis of Internal Translational Efficiency of Brain, Liver, and Serum Variants

H. Thomas, S. Taylor-Robinson, D. Forton, 2004, Journal of Virology.

Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects

H. Thomas, P. Karayiannis, T. Petropoulou, 2003, Journal of medical virology.

Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction

F. Rey, D. Lavillette, F. Cosset, 2015, Journal of Virology.

The role of calf serum in the growth of Chlamydia trachomatis in McCoy cell cultures.

P. Karayiannis, D. Hobson, 1981, Journal of general microbiology.

Isolation of Chlamydia trachomatis from Bartholin's ducts.

P. Karayiannis, D. Hobson, J. Davies, 1978, The British journal of venereal diseases.

Abnormal T-lymphocyte subsets in hemophilia: relation to HLA proteins in plasma products.

H. Thomas, P. Karayiannis, C. Lee, 1984, The New England journal of medicine.

Systematic review: hepatic fibrosis – regression with therapy

C. Zois, E. Tsianos, P. Karayiannis, 2008, Alimentary pharmacology & therapeutics.

Hepatitis G virus infection

M. Chiaramonte, P. Karayiannis, H. Thomas, 1997, The Lancet.

Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine

A. Archimandritis, P. Karayiannis, A. Alexopoulou, 2006, Journal of medical virology.

British Association for the Study of the Liver

A. Perelson, C. Dejong, Y. Ma, 1991 .

Inhibition of Phosphodiesterase 12 results in Antiviral Activity against several RNA Viruses including SARS-CoV-2

D. Beasley, G. Screaton, M. Thursz, 2022, bioRxiv.

A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: characterization and demonstration of protective immunogenicity.

R. Goldin, P. Karayiannis, H. Thomas, 1991, The Journal of general virology.

ducts . trachomatis from Bartholin ' s Isolation of Chlamydia

P. Karayiannis, D. Hobson, J. Davies, 2022 .

Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis.

A. Hatzakis, D. Paraskevis, V. Kalapothaki, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Expression of Noncovalent Hepatitis C Virus Envelope E1-E2 Complexes Is Not Required for the Induction of Antibodies with Neutralizing Properties following DNA Immunization

C. Trépo, O. Vidalin, G. Maertens, 1999, Journal of Virology.

Steatosis and steatohepatitis in postmortem material from Northwestern Greece.

A. Goussia, C. Zois, E. Tsianos, 2010, World journal of gastroenterology.

Circulating IgG Levels in SARS-CoV-2 Convalescent Individuals in Cyprus

Andrea C. Kakouri, C. Deltas, Eirini Christaki, 2021, Journal of clinical medicine.

Monoclonal antibody to HBsAg for chronic hepatitis B virus infection with hypogammaglobulinaemia

H. Thomas, M. Brook, P. Karayiannis, 1990, The Lancet.

Effect of variation in the common “a” determinant on the antigenicity of hepatitis B surface antigen

H. Thomas, R. Gehrke, P. Karayiannis, 2000, Journal of medical virology.

Neurological, neuropsychiatric and psychiatric symptoms during COVID-19 infection and after recovery: a systematic review of observational studies

M. Stavrou, P. Karayiannis, S. Solomou, 2021, medRxiv.